158 related articles for article (PubMed ID: 37974379)
1. Copy number loss of KDM5D may be a predictive biomarker for ATR inhibitor treatment in male patients with pulmonary squamous cell carcinoma.
Ura A; Hayashi T; Komura K; Hosoya M; Takamochi K; Sato E; Saito S; Wakai S; Handa T; Saito T; Kato S; Suzuki K; Yao T;
J Pathol Clin Res; 2024 Jan; 10(1):e350. PubMed ID: 37974379
[TBL] [Abstract][Full Text] [Related]
2. ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D.
Komura K; Yoshikawa Y; Shimamura T; Chakraborty G; Gerke TA; Hinohara K; Chadalavada K; Jeong SH; Armenia J; Du SY; Mazzu YZ; Taniguchi K; Ibuki N; Meyer CA; Nanjangud GJ; Inamoto T; Lee GM; Mucci LA; Azuma H; Sweeney CJ; Kantoff PW
J Clin Invest; 2018 Jul; 128(7):2979-2995. PubMed ID: 29863497
[TBL] [Abstract][Full Text] [Related]
3. Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma.
Sriram KB; Larsen JE; Savarimuthu Francis SM; Wright CM; Clarke BE; Duhig EE; Brown KM; Hayward NK; Yang IA; Bowman RV; Fong KM
PLoS One; 2012; 7(2):e30398. PubMed ID: 22363434
[TBL] [Abstract][Full Text] [Related]
4. Two Splice Variants of Y Chromosome-Located Lysine-Specific Demethylase 5D Have Distinct Function in Prostate Cancer Cell Line (DU-145).
Jangravi Z; Tabar MS; Mirzaei M; Parsamatin P; Vakilian H; Alikhani M; Shabani M; Haynes PA; Goodchild AK; Gourabi H; Baharvand H; Salekdeh GH
J Proteome Res; 2015 Sep; 14(9):3492-502. PubMed ID: 26215926
[TBL] [Abstract][Full Text] [Related]
5. KDM5D Histone Demethylase Identifies Platinum-Tolerant Head and Neck Cancer Cells Vulnerable to Mitotic Catastrophe.
Chen TM; Huang CM; Setiawan SA; Hsieh MS; Sheen CC; Yeh CT
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982384
[TBL] [Abstract][Full Text] [Related]
6. Investigation of Histone Lysine-Specific Demethylase 5D KDM5D) Isoform Expression in Prostate Cancer Cell Lines: a System Approach.
Jangravi Z; Najafi M; Shabani M
Iran Biomed J; 2016; 20(2):117-21. PubMed ID: 26728332
[TBL] [Abstract][Full Text] [Related]
7. Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss.
Sankunny M; Parikh RA; Lewis DW; Gooding WE; Saunders WS; Gollin SM
Genes Chromosomes Cancer; 2014 Feb; 53(2):129-43. PubMed ID: 24327542
[TBL] [Abstract][Full Text] [Related]
8. Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression.
Komura K; Jeong SH; Hinohara K; Qu F; Wang X; Hiraki M; Azuma H; Lee GS; Kantoff PW; Sweeney CJ
Proc Natl Acad Sci U S A; 2016 May; 113(22):6259-64. PubMed ID: 27185910
[TBL] [Abstract][Full Text] [Related]
9. KDM5D inhibit epithelial-mesenchymal transition of gastric cancer through demethylation in the promoter of Cul4A in male.
Shen X; Hu K; Cheng G; Xu L; Chen Z; Du P; Zhuang Z
J Cell Biochem; 2019 Aug; 120(8):12247-12258. PubMed ID: 30864186
[TBL] [Abstract][Full Text] [Related]
10. Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma.
Arseneault M; Monlong J; Vasudev NS; Laskar RS; Safisamghabadi M; Harnden P; Egevad L; Nourbehesht N; Panichnantakul P; Holcatova I; Brisuda A; Janout V; Kollarova H; Foretova L; Navratilova M; Mates D; Jinga V; Zaridze D; Mukeria A; Jandaghi P; Brennan P; Brazma A; Tost J; Scelo G; Banks RE; Lathrop M; Bourque G; Riazalhosseini Y
Sci Rep; 2017 Mar; 7():44876. PubMed ID: 28332632
[TBL] [Abstract][Full Text] [Related]
11. Increased Mars2 expression upon microRNA-4661-5p-mediated KDM5D downregulation is correlated with malignant degree of gastric cancer cells.
Gu J; Chu K
Cell Biol Int; 2021 Oct; 45(10):2118-2128. PubMed ID: 34273914
[TBL] [Abstract][Full Text] [Related]
12. Genomic Copy Number Signatures Uncovered a Genetically Distinct Group from Adenocarcinoma and Squamous Cell Carcinoma in Non-Small Cell Lung Cancer.
Lee E; Moon JW; Wang X; Kim C; Li S; Shin BK; Jung W; Kim HK; Kim HK; Lee JY
Hum Pathol; 2015 Aug; 46(8):1111-20. PubMed ID: 26003479
[TBL] [Abstract][Full Text] [Related]
13. Histone demethylase KDM5D upregulation drives sex differences in colon cancer.
Li J; Lan Z; Liao W; Horner JW; Xu X; Liu J; Yoshihama Y; Jiang S; Shim HS; Slotnik M; LaBella KA; Wu CJ; Dunner K; Hsu WH; Lee R; Khanduri I; Terranova C; Akdemir K; Chakravarti D; Shang X; Spring DJ; Wang YA; DePinho RA
Nature; 2023 Jul; 619(7970):632-639. PubMed ID: 37344599
[TBL] [Abstract][Full Text] [Related]
14. KDM5D inhibits the transcriptional activation of FKBP4 by suppressing the expression of E2F1 in colorectal cancer in males.
Liu M; Gao N
Biochem Pharmacol; 2021 Dec; 194():114814. PubMed ID: 34688635
[TBL] [Abstract][Full Text] [Related]
15. Down-Regulation of a Male-Specific H3K4 Demethylase,
Meyfour A; Pahlavan S; Ansari H; Baharvand H; Salekdeh GH
J Proteome Res; 2019 Dec; 18(12):4277-4282. PubMed ID: 31560558
[TBL] [Abstract][Full Text] [Related]
16. ETV4 promotes the progression of gastric cancer through regulating KDM5D.
Cai LS; Chen QX; Fang SY; Lian MQ; Lian MJ; Cai MZ
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2442-2451. PubMed ID: 32196595
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of the ATR-CHEK1 pathway in oral squamous cell carcinomas.
Parikh RA; Appleman LJ; Bauman JE; Sankunny M; Lewis DW; Vlad A; Gollin SM
Genes Chromosomes Cancer; 2014 Jan; 53(1):25-37. PubMed ID: 24142626
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer.
Inoue Y; Yoshimura K; Mori K; Kurabe N; Kahyo T; Mori H; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
Oncotarget; 2016 May; 7(22):32113-28. PubMed ID: 27050074
[TBL] [Abstract][Full Text] [Related]
19. Lung squamous cell carcinomas with basaloid histology represent a specific molecular entity.
Brambilla C; Laffaire J; Lantuejoul S; Moro-Sibilot D; Mignotte H; Arbib F; Toffart AC; Petel F; Hainaut P; Rousseaux S; Khochbin S; de Reyniès A; Brambilla E
Clin Cancer Res; 2014 Nov; 20(22):5777-86. PubMed ID: 25189482
[TBL] [Abstract][Full Text] [Related]
20. Ataxia-Telangiectasia and RAD3-Related and Ataxia-Telangiectasia-Mutated Proteins in Epithelial Ovarian Carcinoma: Their Expression and Clinical Significance.
Lee B; Lee HJ; Cho HY; Suh DH; Kim K; No JH; Kim H; Kim YB
Anticancer Res; 2015 Jul; 35(7):3909-16. PubMed ID: 26124337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]